CYP4F8 Inhibitors represent a specific category of chemical compounds designed to selectively impede the activity of the CYP4F8 enzyme. CYP4F8, or Cytochrome P450 4F8, belongs to the cytochrome P450 superfamily, a group of enzymes crucial for the metabolism of endogenous and exogenous compounds. The development of inhibitors targeting CYP4F8 is vital for scientific investigations, providing specialized tools to dissect the molecular functions and metabolic processes associated with this particular enzyme. As part of the cytochrome P450 family, CYP4F8 likely participates in the oxidative metabolism of lipids, contributing to the intricate regulation of lipid homeostasis and xenobiotic detoxification within cells.
The synthesis and optimization of CYP4F8 inhibitors require a comprehensive understanding of the enzyme's structural features and its interactions within cellular pathways. These inhibitors are meticulously designed for specificity, aiming to selectively bind to key regions of CYP4F8 and interfere with its normal catalytic activities. By utilizing CYP4F8 inhibitors in experimental contexts, researchers can investigate the consequences of enzyme inhibition on lipid metabolism, shedding light on the specific substrates and metabolic pathways governed by CYP4F8. The study of CYP4F8 inhibitors contributes to the broader understanding of cytochrome P450-mediated metabolism, providing insights into the intricate molecular mechanisms that regulate the biotransformation of lipids and xenobiotics in cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA, inhibiting transcription and preventing the synthesis of CYP4F8 mRNA. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide disrupts protein synthesis, leading to a reduction in CYP4F8 expression by inhibiting translation. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin induces premature termination of protein synthesis, impacting translation and lowering CYP4F8 levels. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin inhibits bacterial RNA polymerase, indirectly suppressing CYP4F8 expression by interfering with transcription. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin hinders protein synthesis by blocking peptidyl transferase activity, leading to reduced CYP4F8 synthesis. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Cordycepin interferes with mRNA synthesis, impacting transcription and contributing to the downregulation of CYP4F8. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic acid inhibits inosine monophosphate dehydrogenase, indirectly affecting CYP4F8 expression by disrupting purine synthesis. | ||||||
Blasticidin S Hydrochloride | 3513-03-9 | sc-204655A sc-204655 | 25 mg 100 mg | $367.00 $520.00 | 20 | |
Blasticidin S induces premature termination during translation, inhibiting protein synthesis and reducing CYP4F8 levels. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil interferes with RNA synthesis, affecting the expression of CYP4F8 by disrupting the production of mRNA. | ||||||